当前位置: 首页 >> 检索结果
共有 1652 条符合本次的查询结果, 用时 6.9032127 秒

801. The role of Cdx genes in the mammalian gut.

作者: F Beck.
来源: Gut. 2004年53卷10期1394-6页

802. H pylori antibiotic resistance: prevalence, importance, and advances in testing.

作者: F Mégraud.
来源: Gut. 2004年53卷9期1374-84页

803. Biologics in inflammatory bowel disease: how much progress have we made?

作者: W J Sandborn.;W A Faubion.
来源: Gut. 2004年53卷9期1366-73页

804. Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences.

作者: M Pascu.;P Martus.;M Höhne.;B Wiedenmann.;U Hopf.;E Schreier.;T Berg.
来源: Gut. 2004年53卷9期1345-51页
There is growing evidence that the response of hepatitis C virus (HCV) genotype 1b infected patients towards interferon (IFN) therapy is influenced by the number of mutations within the carboxy terminal region of the NS5A gene, the interferon sensitivity determining region (ISDR).

805. Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport?

作者: J Schölmerich.;D Schacherer.
来源: Gut. 2004年53卷9期1224-6页

806. Endoscopic mucosal resection: an evolving therapeutic strategy for non-polypoid colorectal neoplasia.

作者: R Kiesslich.;M F Neurath.
来源: Gut. 2004年53卷9期1222-4页

807. Experimental Helicobacter pylori infection in humans: a multifaceted challenge.

作者: P Michetti.
来源: Gut. 2004年53卷9期1220-1页

808. Is gastric cancer preventable?

作者: P Correa.
来源: Gut. 2004年53卷9期1217-9页
Gastric cancer is a major health burden worldwide and prevention is the most promising strategy to control the disease. The available scientific evidence indicates that curing Helicobacter pylori infection results in a modest retardation of the precancerous process but does not prevent all cancers. Individuals at the highest risk should be cured of their infection and monitored endoscopically to detect dysplasia and "early" cancer, amenable to successful treatment.

809. Guidelines for the management of inflammatory bowel disease in adults.

作者: M J Carter.;A J Lobo.;S P L Travis.; .
来源: Gut. 2004年53 Suppl 5卷Suppl 5期V1-16页

810. Endoscopic antireflux procedures.

作者: J Arts.;J Tack.;J P Galmiche.
来源: Gut. 2004年53卷8期1207-14页

811. Brain imaging and functional gastrointestinal disorders: has it helped our understanding?

作者: A R Hobson.;Q Aziz.
来源: Gut. 2004年53卷8期1198-206页

812. Iron, anaemia, and inflammatory bowel diseases.

作者: C Gasche.;M C E Lomer.;I Cavill.;G Weiss.
来源: Gut. 2004年53卷8期1190-7页
Iron deficiency anaemia is one of the most common disorders in the world. Also, one third of inflammatory bowel disease (IBD) patients suffer from recurrent anaemia. Anaemia has significant impact on the quality of life of affected patients. Chronic fatigue, a frequent IBD symptom itself, is commonly caused by anaemia and may debilitate patients as much as abdominal pain or diarrhoea. Common therapeutic targets are the mechanisms behind anaemia of chronic disease and iron deficiency. It is our experience that virtually all patients with IBD associated anaemia can be successfully treated with a combination of iron sucrose and erythropoietin, which then may positively affect the misled immune response in IBD.

813. New thoughts on managing obesity.

作者: P G Kopelman.;C Grace.
来源: Gut. 2004年53卷7期1044-53页

814. The CD40/CD40L costimulatory pathway in inflammatory bowel disease.

作者: S Danese.;M Sans.;C Fiocchi.
来源: Gut. 2004年53卷7期1035-43页

815. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux.

作者: D Sifrim.;D Castell.;J Dent.;P J Kahrilas.
来源: Gut. 2004年53卷7期1024-31页
To date, most concepts on the frequency of gastro-oesophageal reflux episodes and the efficiency of the antireflux barrier have been based on inferences derived from measurement of oesophageal pH. The development of intraluminal impedance monitoring has highlighted the fact that pH monitoring does not detect all gastro-oesophageal reflux events when little or no acid is present in the refluxate, even if special pH tracing analysis criteria are used. In November 2002, a workshop took place at which 11 specialists in the field of gastro-oesophageal reflux disease discussed and criticised all currently available techniques for measurement of reflux. Here, a summary of their conclusions and recommendations of how to achieve the best results from the various techniques now available for reflux measurement is presented.

816. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.

作者: T H J Florin.;N Pandeya.;G L Radford-Smith.
来源: Gut. 2004年53卷7期973-9页
Appendicectomy and smoking are environmental factors that are known to influence ulcerative colitis (UC). The phenotype of UC is different in patients with coexistent primary sclerosing cholangitis (PSC). This study investigates the interaction of appendicectomy and PSC on the epidemiology and clinical behaviour of colitis.

817. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

作者: F Fiorica.;D Di Bona.;F Schepis.;A Licata.;L Shahied.;A Venturi.;A M Falchi.;A Craxì.;C Cammà.
来源: Gut. 2004年53卷7期925-30页
The benefit of neoadjuvant chemoradiotherapy in oesophageal cancer has been extensively studied but data on survival are still equivocal.

818. Stem cell in gastrointestinal structure and neoplastic development.

作者: M Brittan.;N A Wright.
来源: Gut. 2004年53卷6期899-910页

819. Prospects for extracorporeal liver support.

作者: R Jalan.;S Sen.;R Williams.
来源: Gut. 2004年53卷6期890-8页

820. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.

作者: N Sharma.;C Donnellan.;C Preston.;B Delaney.;G Duckett.;P Moayyedi.
来源: Gut. 2004年53 Suppl 4卷Suppl 4期iv58-65页
Symptoms are an important outcome for measurement in clinical trials into gastro-oesophageal reflux disease, but the optimal approach to symptom assessment has not been formally evaluated. The authors conducted a systematic review to assess how reflux symptoms have been evaluated and how well these correlate with oesophagitis healing and relapse.
共有 1652 条符合本次的查询结果, 用时 6.9032127 秒